ID   EGR1_RAT                Reviewed;         508 AA.
AC   P08154; Q53YM5;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1990, sequence version 2.
DT   02-OCT-2024, entry version 181.
DE   RecName: Full=Early growth response protein 1;
DE            Short=EGR-1;
DE   AltName: Full=Nerve growth factor-induced protein A {ECO:0000303|PubMed:2492104};
DE            Short=NGFI-A {ECO:0000303|PubMed:2492104};
DE   AltName: Full=Transcription factor Zif268;
DE   AltName: Full=Zinc finger protein Krox-24;
GN   Name=Egr1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3672127; DOI=10.1126/science.3672127;
RA   Milbrandt J.;
RT   "A nerve growth factor-induced gene encodes a possible transcriptional
RT   regulatory factor.";
RL   Science 238:797-799(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND INDUCTION BY GROWTH FACTORS.
RX   PubMed=2492104; DOI=10.1073/pnas.86.1.377;
RA   Changelian P.S., Feng P., King T.C., Milbrandt J.;
RT   "Structure of the NGFI-A gene and detection of upstream sequences
RT   responsible for its transcriptional induction by nerve growth factor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:377-381(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Midbrain;
RA   Ju S.K.;
RT   "Cloning and sequencing of cDNA encoding EGR1 from rat.";
RL   Submitted (FEB-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INDUCTION BY ISCHEMIA.
RX   PubMed=1859855; DOI=10.1091/mbc.2.3.251;
RA   Bonventre J.V., Sukhatme V.P., Bamberger M., Ouellette A.J., Brown D.;
RT   "Localization of the protein product of the immediate early growth response
RT   gene, Egr-1, in the kidney after ischemia and reperfusion.";
RL   Cell Regul. 2:251-260(1991).
RN   [5]
RP   FUNCTION, AND MUTAGENESIS OF ILE-265.
RX   PubMed=8413279; DOI=10.1128/mcb.13.11.6858-6865.1993;
RA   Russo M.W., Matheny C., Milbrandt J.;
RT   "Transcriptional activity of the zinc finger protein NGFI-A is influenced
RT   by its interaction with a cellular factor.";
RL   Mol. Cell. Biol. 13:6858-6865(1993).
RN   [6]
RP   FUNCTION.
RX   PubMed=15220929; DOI=10.1038/nn1276;
RA   Weaver I.C., Cervoni N., Champagne F.A., D'Alessio A.C., Sharma S.,
RA   Seckl J.R., Dymov S., Szyf M., Meaney M.J.;
RT   "Epigenetic programming by maternal behavior.";
RL   Nat. Neurosci. 7:847-854(2004).
CC   -!- FUNCTION: Transcriptional regulator (PubMed:8413279). Recognizes and
CC       binds to the DNA sequence 5'-GCG(T/G)GGGCG-3'(EGR-site) in the promoter
CC       region of target genes (PubMed:15220929). Binds double-stranded target
CC       DNA, irrespective of the cytosine methylation status (By similarity).
CC       Regulates the transcription of numerous target genes, and thereby plays
CC       an important role in regulating the response to growth factors, DNA
CC       damage, and ischemia. Plays a role in the regulation of cell survival,
CC       proliferation and cell death. Activates expression of p53/TP53 and
CC       TGFB1, and thereby helps prevent tumor formation. Required for normal
CC       progress through mitosis and normal proliferation of hepatocytes after
CC       partial hepatectomy. Mediates responses to ischemia and hypoxia;
CC       regulates the expression of proteins such as IL1B and CXCL2 that are
CC       involved in inflammatory processes and development of tissue damage
CC       after ischemia. Regulates biosynthesis of luteinizing hormone (LHB) in
CC       the pituitary (By similarity). Regulates the amplitude of the
CC       expression rhythms of clock genes: BMAL1, PER2 and NR1D1 in the liver
CC       via the activation of PER1 (clock repressor) transcription. Regulates
CC       the rhythmic expression of core-clock gene BMAL1 in the suprachiasmatic
CC       nucleus (SCN) (By similarity). Regulates biosynthesis of glucocorticoid
CC       receptor GR/NR3C1 in the hippocampus and thereby may play a role in the
CC       behavioral and hypothalamic-pituitary-adrenal responses to stress in
CC       offspring (PubMed:15220929). {ECO:0000250|UniProtKB:P08046,
CC       ECO:0000250|UniProtKB:P18146, ECO:0000269|PubMed:8413279}.
CC   -!- SUBUNIT: Interacts with SNAI1 and SP1 upon 12-O-tetradecanoylphorbol-
CC       13-acetate (TPA) induction. {ECO:0000250|UniProtKB:P18146}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:1859855}. Cytoplasm
CC       {ECO:0000250|UniProtKB:P18146}.
CC   -!- TISSUE SPECIFICITY: Detected in kidney thick ascending limbs and
CC       collecting ducts (at protein level). {ECO:0000269|PubMed:1859855}.
CC   -!- INDUCTION: By growth factors (PubMed:2492104). Rapidly and transiently
CC       up-regulated in response to ischemia (PubMed:1859855).
CC       {ECO:0000269|PubMed:1859855, ECO:0000269|PubMed:2492104}.
CC   -!- DOMAIN: Binds to DNA motifs with the sequence 5'-GCG(T/G)GGGCG-3' via
CC       its C2H2-type zinc fingers. The first, most N-terminal zinc finger
CC       binds to the 3'-GCG motif, the middle zinc finger interacts with the
CC       central TGG motif, and the C-terminal zinc finger binds to the 5'-GCG
CC       motif. Binds double-stranded target DNA, irrespective of the cytosine
CC       methylation status. Has reduced affinity for target DNA where the
CC       cytosines have been oxidized to 5-hydroxymethylcytosine. Does not bind
CC       target DNA where the cytosines have been oxidized to 5-formylcytosine
CC       or 5-carboxylcytosine. {ECO:0000250|UniProtKB:P18146}.
CC   -!- SIMILARITY: Belongs to the EGR C2H2-type zinc-finger protein family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M18416; AAA61927.1; -; mRNA.
DR   EMBL; J04154; AAA60740.1; -; Genomic_DNA.
DR   EMBL; AY551092; AAS58455.1; -; mRNA.
DR   PIR; A32225; A32225.
DR   RefSeq; NP_036683.1; NM_012551.2.
DR   AlphaFoldDB; P08154; -.
DR   SMR; P08154; -.
DR   STRING; 10116.ENSRNOP00000026303; -.
DR   PhosphoSitePlus; P08154; -.
DR   PaxDb; 10116-ENSRNOP00000026303; -.
DR   GeneID; 24330; -.
DR   KEGG; rno:24330; -.
DR   UCSC; RGD:2544; rat.
DR   AGR; RGD:2544; -.
DR   CTD; 1958; -.
DR   RGD; 2544; Egr1.
DR   eggNOG; KOG1721; Eukaryota.
DR   HOGENOM; CLU_043235_2_0_1; -.
DR   InParanoid; P08154; -.
DR   OrthoDB; 2912670at2759; -.
DR   PhylomeDB; P08154; -.
DR   PRO; PR:P08154; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0000785; C:chromatin; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IMP:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0003690; F:double-stranded DNA binding; IDA:RGD.
DR   GO; GO:0010385; F:double-stranded methylated DNA binding; ISO:RGD.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0044729; F:hemi-methylated DNA-binding; ISO:RGD.
DR   GO; GO:0035035; F:histone acetyltransferase binding; ISO:RGD.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; IDA:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISO:RGD.
DR   GO; GO:0008270; F:zinc ion binding; ISO:RGD.
DR   GO; GO:0030509; P:BMP signaling pathway; ISO:RGD.
DR   GO; GO:0071236; P:cellular response to antibiotic; IEP:RGD.
DR   GO; GO:0071320; P:cellular response to cAMP; IEP:RGD.
DR   GO; GO:0071372; P:cellular response to follicle-stimulating hormone stimulus; IEP:RGD.
DR   GO; GO:0071480; P:cellular response to gamma radiation; ISO:RGD.
DR   GO; GO:0071371; P:cellular response to gonadotropin stimulus; IEP:RGD.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; IEP:RGD.
DR   GO; GO:0071504; P:cellular response to heparin; IDA:UniProtKB.
DR   GO; GO:0071455; P:cellular response to hyperoxia; IEP:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEP:RGD.
DR   GO; GO:0098759; P:cellular response to interleukin-8; ISS:UniProtKB.
DR   GO; GO:0071317; P:cellular response to isoquinoline alkaloid; IEP:RGD.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0071506; P:cellular response to mycophenolic acid; IDA:UniProtKB.
DR   GO; GO:0071383; P:cellular response to steroid hormone stimulus; IEP:RGD.
DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0007623; P:circadian rhythm; IEP:RGD.
DR   GO; GO:0060086; P:circadian temperature homeostasis; ISS:UniProtKB.
DR   GO; GO:0044849; P:estrous cycle; ISS:UniProtKB.
DR   GO; GO:0072110; P:glomerular mesangial cell proliferation; IMP:UniProtKB.
DR   GO; GO:0070498; P:interleukin-1-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0007611; P:learning or memory; IMP:RGD.
DR   GO; GO:0045475; P:locomotor rhythm; ISS:UniProtKB.
DR   GO; GO:0007616; P:long-term memory; IMP:RGD.
DR   GO; GO:0060291; P:long-term synaptic potentiation; IEP:RGD.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0048709; P:oligodendrocyte differentiation; IEP:RGD.
DR   GO; GO:0032722; P:positive regulation of chemokine production; ISS:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IMP:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:RGD.
DR   GO; GO:0044029; P:positive regulation of gene expression via chromosomal CpG island demethylation; ISO:RGD.
DR   GO; GO:0072303; P:positive regulation of glomerular metanephric mesangial cell proliferation; IMP:UniProtKB.
DR   GO; GO:0046886; P:positive regulation of hormone biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0032731; P:positive regulation of interleukin-1 beta production; ISS:UniProtKB.
DR   GO; GO:1902895; P:positive regulation of miRNA transcription; ISO:RGD.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IMP:RGD.
DR   GO; GO:1901875; P:positive regulation of post-translational protein modification; ISO:RGD.
DR   GO; GO:0014911; P:positive regulation of smooth muscle cell migration; IMP:RGD.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IMP:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:RGD.
DR   GO; GO:0042981; P:regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0048169; P:regulation of long-term neuronal synaptic plasticity; IMP:RGD.
DR   GO; GO:2000182; P:regulation of progesterone biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0033233; P:regulation of protein sumoylation; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0001975; P:response to amphetamine; IEP:RGD.
DR   GO; GO:0034465; P:response to carbon monoxide; IEP:RGD.
DR   GO; GO:0042220; P:response to cocaine; IEP:RGD.
DR   GO; GO:0051602; P:response to electrical stimulus; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0032354; P:response to follicle-stimulating hormone; IEP:RGD.
DR   GO; GO:0009749; P:response to glucose; ISO:RGD.
DR   GO; GO:0034698; P:response to gonadotropin; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; ISS:UniProtKB.
DR   GO; GO:0032868; P:response to insulin; ISO:RGD.
DR   GO; GO:0002931; P:response to ischemia; IDA:UniProtKB.
DR   GO; GO:0043278; P:response to morphine; IEP:RGD.
DR   GO; GO:0071873; P:response to norepinephrine; IEP:RGD.
DR   GO; GO:0031667; P:response to nutrient levels; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0035914; P:skeletal muscle cell differentiation; ISO:RGD.
DR   GO; GO:0030217; P:T cell differentiation; ISO:RGD.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 3.
DR   InterPro; IPR021839; EGR1_C.
DR   InterPro; IPR021849; EGR_N.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR23235:SF42; EARLY GROWTH RESPONSE PROTEIN 1; 1.
DR   PANTHER; PTHR23235; KRUEPPEL-LIKE TRANSCRIPTION FACTOR; 1.
DR   Pfam; PF11914; DUF3432; 1.
DR   Pfam; PF11928; DUF3446; 1.
DR   Pfam; PF00096; zf-C2H2; 3.
DR   SMART; SM00355; ZnF_C2H2; 3.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 2.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 3.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 3.
PE   1: Evidence at protein level;
KW   Activator; Biological rhythms; Cytoplasm; DNA-binding; Isopeptide bond;
KW   Metal-binding; Nucleus; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..508
FT                   /note="Early growth response protein 1"
FT                   /id="PRO_0000047111"
FT   REPEAT          413..420
FT                   /note="1"
FT   REPEAT          421..428
FT                   /note="2"
FT   REPEAT          429..436
FT                   /note="3"
FT   REPEAT          437..444
FT                   /note="4"
FT   REPEAT          445..452
FT                   /note="5"
FT   REPEAT          453..460
FT                   /note="6"
FT   REPEAT          462..468
FT                   /note="7"
FT   ZN_FING         311..335
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         341..363
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         369..391
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          18..78
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          136..210
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          292..311
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          382..453
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          413..468
FT                   /note="7 X 8 AA tandem repeats of [TS](2)-[FY]-[PS]-S-P-
FT                   [GSAV]-X"
FT   COMPBIAS        28..78
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        136..202
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        404..453
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            309
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250|UniProtKB:P18146"
FT   SITE            320
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250|UniProtKB:P08046"
FT   SITE            324
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250|UniProtKB:P08046"
FT   SITE            330
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250|UniProtKB:P18146"
FT   SITE            348
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250|UniProtKB:P08046"
FT   SITE            352
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250|UniProtKB:P18146"
FT   SITE            376
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250|UniProtKB:P18146"
FT   SITE            380
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250|UniProtKB:P18146"
FT   SITE            386
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250|UniProtKB:P18146"
FT   CROSSLNK        278
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P18146"
FT   MUTAGEN         265
FT                   /note="I->F: Increases transcriptional activity."
FT                   /evidence="ECO:0000269|PubMed:8413279"
SQ   SEQUENCE   508 AA;  53935 MW;  3947BBA871BB8FA8 CRC64;
     MDNYPKLEEM MLLSNGAPQF LGAAGTPEGS GGNNSSSSSS SSSGGGGGGG SNSGSSAFNP
     QGEPSEQPYE HLTTESFSDI ALNNEKALVE TSYPSQTTRL PPITYTGRFS LEPAPNSGNT
     LWPEPLFSLV SGLVSMTNPP TSSSSAPSPA ASSSSSASQS PPLSCAVPSN DSSPIYSAAP
     TFPTPNTDIF PEPQSQAFPG SAGTALQYPP PAYPATKGGF QVPMIPDYLF PQQQGDLSLG
     TPDQKPFQGL ENRTQQPSLT PLSTIKAFAT QSGSQDLKAL NNTYQSQLIK PSRMRKYPNR
     PSKTPPHERP YACPVESCDR RFSRSDELTR HIRIHTGQKP FQCRICMRNF SRSDHLTTHI
     RTHTGEKPFA CDICGRKFAR SDERKRHTKI HLRQKDKKAD KSVVASSAAS SLSSYPSPVA
     TSYPSPATTS FPSPVPTSYS SPGSSTYPSP AHSGFPSPSV ATTYASVPPA FPAQVSTFQS
     AGVSNSFSTS TGLSDMTATF SPRTIEIC
//
